Tab Application Banner
  • Users Online: 1492
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
PERSPECTIVE
Year : 2015  |  Volume : 10  |  Issue : 5  |  Page : 3-5

Which way is vasculitis research heading?


Division of Immunity & Infection, College of Medicine and Dentistry, University of Birmingham, UK

Correspondence Address:
Paul Bacon
Division of Immunity & Infection, College of Medicine and Dentistry, University of Birmingham, UK

Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.1016/j.injr.2015.08.004

Rights and Permissions

Clinical research is driving the improved prognosis for patients with systemic vasculitis. The major progress has been in ANCA-related vasculitis, where the need now is to incorporate the lessons from limited term controlled trials into evidence-based treat-to-target regimes related to individual responses over a prolonged period. This perspective examines the research aimed to establish the biomarkers needed for such an approach to succeed. It also looks at the more basic research needed to establish the aetio-pathogenesis of other major forms of vasculitis so that rational treatments can be devised for them too.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed611    
    Printed6    
    Emailed0    
    PDF Downloaded317    
    Comments [Add]    

Recommend this journal